enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. FibroGen regains rights to anemia drug from AstraZeneca - AOL

   www.aol.com/news/fibrogen-regains-rights-anemia...

   (Reuters) -FibroGen Inc said on Monday it is regaining rights to the anemia drug, roxadustat, from AstraZeneca in the United States and certain other territories after the companies agreed to ...

3. Don’t Go Bargain Hunting on FibroGen Stock, Says Analyst - AOL

   www.aol.com/news/don-t-bargain-hunting-fibrogen...

   When looking at the case of FibroGen’s (FGEN) roxadustat, the biotech’s therapy for sufferers of anemia related to chronic kidney disease (CKD), H.C. Wainwright’s Edwin Zhang thinks a repeat ...

4. Is Fibrogen Still a Buy Following Data Analysis Faux Pas ...

   www.aol.com/news/fibrogen-still-buy-following...

   No one likes being given the wrong information. Investors reacted in dismay and sent Fibrogen (FGEN) shares deep into the red following the company's embarrassing announcement. The biotech company ...

5. FibroGen Stock Gives Every Indication Of Being Possible Value ...

   www.aol.com/news/fibrogen-stock-gives-every...

   The stock of FibroGen (NAS:FGEN, 30-year Financials) is estimated to be possible value trap, according to GuruFocus Value calculation.

6. FibroGen (FGEN) Reports Q4 Loss, Lags Revenue Estimates - AOL

   www.aol.com/news/fibrogen-fgen-reports-q4-loss...

   FibroGen (FGEN) delivered earnings and revenue surprises of -113.24% and 62.59%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

7. Analysts Estimate FibroGen (FGEN) to Report a Decline in ...

   www.aol.com/news/analysts-estimate-fibrogen-fgen...

   For premium support please call: 800-290-4726 more ways to reach us

8. FibroGen (NASDAQ:FGEN) adds US$108m to market cap in ... - AOL

   www.aol.com/news/fibrogen-nasdaq-fgen-adds-us...

   This month, we saw the FibroGen, Inc. ( NASDAQ:FGEN ) up an impressive 32%. But spare a thought for the long term...

9. FibroGen's (NASDAQ:FGEN) Shareholders Are Down 57% On Their ...

   www.aol.com/news/fibrogens-nasdaq-fgen...

   For premium support please call: 800-290-4726 more ways to reach us